Sun Pharma Wins CDSCO Nod for Generic Oral Semaglutide Pill
Sun Pharmaceutical Industries has received approval from the Central Drugs Standard Control Organisation (CDSCO) to manufacture and market a generic […]
GLP-1
SCHOTT Poonawalla Renamed SCHOTT Pharma India as Prefillable Syringe and Cartridge Capacity Expands for Biologics, GLP-1s
SCHOTT Poonawalla is now SCHOTT Pharma India, effective 28 October 2026. Ownership and operations are unchanged, but the rebrand ties India’s only glass prefillable syringe maker, which produces 3 billion+ containers a year, closer to its German parent as it adds syringe and cartridge capacity for biologics, biosimilars and GLP-1s.
Novo Nordisk Cuts Wegovy Price in South Africa for Second Time
Novo Nordisk has reduced the price of its semaglutide-based weight-loss drug Wegovy in South Africa for the second time since […]
Dr Reddy’s Gears Up for March Launch of Generic Semaglutide ‘Obeda’ in India
Dr Reddy’s Laboratories is preparing to introduce its generic semaglutide injection in India, likely to be marketed under the brand […]
From GLP-1 to herbals: The Role of botanicals in metabolic health
Metabolic health reflects how effectively the body processes and uses energy from food, determined by markers such as blood sugar, […]
